Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04561297 · ClinicalTrials.gov registry record · NA
Assessing the Utility of Tissue Dielectric Constant (TDC) Measurements to Differentiate Breast Cancer From Healthy Breasts
A NA study, sponsored by Nova Southeastern University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04561297 is a NA study that has completed, run by Nova Southeastern University. The registered enrollment target is 60 participants.
The verdict
NCT04561297, a NA study, has completed, sponsored by Nova Southeastern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Patients with pending breast biopsies will have the tumor site's tissue dielectric constant (TDC) measured prior to the biopsy. Similar TDC measurements will be made at a standard breast site on the biopsied breast and on mirrored sites on the non-affected breast.
Interventions
- DIAGNOSTIC_TEST TDC differential value
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-02-08 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04561297
The ClinicalTrials.gov registry entry for NCT04561297 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TDC differential value is the first listed.
NCT04561297 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04561297 about?
NCT04561297 is a clinical study titled "Assessing the Utility of Tissue Dielectric Constant (TDC) Measurements to Differentiate Breast Cancer From Healthy Breasts". Patients with pending breast biopsies will have the tumor site's tissue dielectric constant (TDC) measured prior to the biopsy. Similar TDC measurements will be made at a standard breast site on the biopsied breast and on mirrored sites on the non-affected breast.
What is the current status of trial NCT04561297?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2019-02-08. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT04561297?
The interventions under investigation include: TDC differential value (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04561297?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.